Therefore, factors identified as risk factors for these side effects [25], including age, left ventricular ejection fraction, eGFR, history of diabetes, history of hypertension, baseline blood pressure, and the use of mineralocorticoid receptor antagonists, beta-blockers, and steroids at the initiation of SV, were analyzed. This evidence concerns the gene NR3C2 and hypertensive disorder.